Subscribe to RSS
DOI: 10.1055/s-0032-1315037
Genetische Untersuchungen in der Kardiologie – „Hands-on“
Genetic Investigations in Cardiology – Hands onPublication History
Publication Date:
13 December 2012 (online)
Zusammenfassung
Viele, obgleich seltene Herzerkrankungen, sind familiär und haben eine genetische Ursache. Neben Kardiomyopathien und idiopathischen Herzrhythmusstörungen gibt es zunehmend Hinweise, dass auch angeborene Herzfehler genetisch verursacht sind. Die Bewertung eines molekulargenetischen Befundes hinsichtlich der klinischen Ausprägung und die sorgsame Aufarbeitung der Familienanamnese stellen weiterhin Anforderungen dar, die im üblichen, fachärztlichen Kontext mit Zeitaufwand und Detailliebe verbunden und daher nicht so einfach zu bewältigen sind. In der beiliegenden Kurzübersicht finden sich daher praktische Hinweise zu den gesetzlichen Rahmenbedingungen und zu genetischen Grundlagen einiger ausgewählter Erkrankungen.
Abstract
To date, inherited cardiac disorders are quite rare and have a multifactorial genetic basis. In addition to cardiomyopathies and primary electrical heart diseases also some of the congenital heart diseases are going to be deciphered as genetically determined, at least in part. In consequence, knowledge of the current national legal conditions to perform genetic testing is important for cardiologists. This will be part of the following short summary.
-
Literatur
- 1 Ackerman MJ, Priori SG, Willems S et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm 2011; 8: 1308-1339
- 2 Gollob MH, Blier L, Brugada R et al. Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position paper. Can J Cardiol 2011; 27: 232-245
- 3 Gersh BJ, Maron BJ, Bonow RO et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 124: e783-e831
- 4 Schulze-Bahr E, Wang Q, Wedekind H et al. KCNE1 mutations cause Jervell and Lange-Nielsen syndrome. Nat Genet 1997; 17: 267-268
- 5 Gollob MH, Jones DL, Krahn AD et al. Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med 2006; 354: 2677-2688
- 6 Thibodeau IL, Xu J, Li Q et al. Paradigm of genetic mosaicism and lone atrial fibrillation: physiological characterization of a connexin 43-deletion mutant identified from atrial tissue. Circulation 2010; 122: 236-244
- 7 Etheridge SP, Bowles NE, Arrington CB et al. Somatic mosaicism contributes to phenotypic variation in Timothy syndrome. Am J Med Genet A 2011; 155?A: 2578-2583
- 8 Esposito G, Butler TL, Blue GM et al. Somatic mutations in NKX2-5, GATA4, and HAND1 are not a common cause of tetralogy of Fallot or hypoplastic left heart. Am J Med Genet A 2011; 155?A: 2416-2421
- 9 Oliva A, Brugada R, DʼAloja E et al. State of the art in forensic investigation of sudden cardiac death. Am J Forensic Med Pathol 2011; 32: 1-16
- 10 Basso C, Carturan E, Pilichou K et al. Sudden cardiac death with normal heart: molecular autopsy. Cardiovasc Pathol 2010; 19: 321-325
- 11 Semsarian C, Hamilton RM. Key role of the molecular autopsy in sudden unexpected death. Heart Rhythm 2012; 9: 145-150
- 12 Ackerman MJ. State of postmortem genetic testing known as the cardiac channel molecular autopsy in the forensic evaluation of unexplained sudden cardiac death in the young. Pacing Clin Electrophysiol 2009; 32 Suppl 2: S86-S89